Jill Wykosky

Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA

David A. Nathanson, Beatrice Gini, Jack Mottahedeh et al. · Science · 2013 · 690 citations · Full text

Medicine, Oncology, Pharmacology +16

EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme

Jill Wykosky, Denise M. Gibo, Constance A. Stanton et al. · Molecular Cancer Research · 2005 · 287 citations · Full text

Medicine, Neuroscience, Oncology +17

Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor

Jill Wykosky, Enzo Palma, Denise M. Gibo et al. · Oncogene · 2008 · 138 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +6

A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in Glioblastoma

Renee Read, Tim R. Fenton, German G. Gomez et al. · PLoS Genetics · 2013 · 133 citations · Full text

Medicine, Molecular Biology, Oncology +17

Interleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy

Jill Wykosky, Denise M. Gibo, Constance A. Stanton et al. · Clinical Cancer Research · 2008 · 104 citations · Full text

Medicine, Oncology, Pathology +15